Few Want to Receive Skin Cancer Biopsy Results Face-to-Face

This article originally appeared here.
Share this content:
Few Want to Receive Skin Cancer Biopsy Results Face-to-Face
Few Want to Receive Skin Cancer Biopsy Results Face-to-Face

FRIDAY, Feb. 12, 2016 (HealthDay News) -- For patients with suspected malignant melanoma or squamous cell carcinoma, most patients are happy to receive biopsy results by letter or telephone, according to a research letter published online Feb. 8 in the British Journal of Dermatology.

Nicola Cooke and Graham B. Colver, B.M., B.Ch., from the Chesterfield Royal Hospital NHS Foundation Trust in the United Kingdom, explored communication methods for conveying a diagnosis of skin cancer to patients. They recruited 77 patients with suspected malignant melanoma or squamous cell carcinoma. Clinicians explained that patients would receive diagnosis by telephone, letter, or face-to-face after biopsy; patients were offered a leaflet discussing the implications of a cancer diagnosis. Patients were reminded of the three alternatives when they attended for their diagnostic biopsy and their choice was recorded. Patients were surveyed one month after receiving their biopsy results regarding their satisfaction with communication methods.

The researchers found that 47, 37, 11, and 5 percent of respondents had chosen to receive their diagnosis by letter, telephone, face-to-face, or a combination of two methods, respectively. Eighty-nine percent of respondents received their results in the manner they had selected. Overall, 94 percent of patients were happy with the way they received their diagnosis. Eighty percent of participants were happy with their original choice of communication method, and only 11 percent reported that they would have preferred a different method.

"Conveying bad news in a face-to-face meeting may not be best for every skin cancer patient," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »